Back
Catalyst Pharmaceuticals Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
64
CPRX
Catalyst Pharmaceuticals
Last Price:
$22.53
Seasonality Move:
5.36%
7 Day Trial
ALL ACCESS PASS
$
7

Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight buying pressure.
Catalyst Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.3 | Buy |
20-day SMA: | 23.52 | Sell |
50-day SMA: | 22.72 | Sell |
200-day SMA: | 20.88 | Buy |
8-day EMA: | 22.47 | Buy |
20-day EMA: | 20.16 | Buy |
50-day EMA: | 13.23 | Buy |
200-day EMA: | 4.44 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.56 | Buy |
Relative Strength Index (14 RSI): | 48.15 | Sell |
Chaikin Money Flow: | 301929 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.88 - 24.6) | Sell |
Bollinger Bands (100): | (21.21 - 23.43) | Buy |
Catalyst Pharmaceuticals Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 22.52 while CPRX 8-day simple moving average is 22.30, which is a Buy signal.
-
The stock price of CPRX is 22.52 while Catalyst Pharmaceuticals 20-day SMA is 23.52, which makes it a Sell.
-
Catalyst Pharmaceuticals 50-day simple moving average is 22.72 while CPRX share price is 22.52, making it a Sell technically.
-
CPRX stock price is 22.52 and Catalyst Pharmaceuticals 200-day simple moving average is 20.88, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
64
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a BuyThe current Catalyst Pharmaceuticals [CPRX] share price is $22.52. The Score for CPRX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.7B
Price in USD:
22.52
Share Volume:
720.9K
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
26.16
52-Week Low:
14.47
Buy
64
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?The Catalyst Pharmaceuticals stock price is 22.52 USD today.
-
Will CPRX stock go up or go down?Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Catalyst Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 22.52 while CPRX 8-day exponential moving average is 22.47, which is a Buy signal.
-
The stock price of CPRX is 22.52 while Catalyst Pharmaceuticals 20-day EMA is 20.16, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day exponential moving average is 13.23 while CPRX share price is 22.52, making it a Buy technically.
-
CPRX stock price is 22.52 and Catalyst Pharmaceuticals 200-day simple moving average is 4.44, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.11 per share, and an increase next year of $0.24 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
-
CPRX Moving Average Covergence Divergence (MACD) indicator is 3.56, suggesting Catalyst Pharmaceuticals is a Buy
-
Catalyst Pharmaceuticals Relative Strength Index (RSI) is 48.15, which suggest Catalyst Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Catalyst Pharmaceuticals is (21.88 - 24.6), which suggest Catalyst Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Catalyst Pharmaceuticals is (21.21 - 23.43), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.